Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cipla
Merck
UBS
Farmers Insurance
Covington
Moodys
Dow
US Department of Justice

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020788

« Back to Dashboard

NDA 020788 describes PROPECIA, which is a drug marketed by Merck and is included in one NDA. It is available from three suppliers. Additional details are available on the PROPECIA profile page.

The generic ingredient in PROPECIA is finasteride. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the finasteride profile page.
Summary for 020788
Tradename:PROPECIA
Applicant:Merck
Ingredient:finasteride
Patents:0
Therapeutic Class:Genitourinary Agents
Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 020788
Mechanism of Action5-alpha Reductase Inhibitors
Medical Subject Heading (MeSH) Categories for 020788
Suppliers and Packaging for NDA: 020788
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROPECIA finasteride TABLET;ORAL 020788 NDA Merck Sharp & Dohme Corp. 0006-0071 N 0006-0071-07
PROPECIA finasteride TABLET;ORAL 020788 NDA Merck Sharp & Dohme Corp. 0006-0071 N 0006-0071-31

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Dec 19, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020788

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Sign Up ➤ Sign Up
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Sign Up ➤ Sign Up
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Sign Up ➤ Sign Up
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
Healthtrust
Cipla
Argus Health
Merck
Express Scripts
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.